These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1154325)

  • 1. Letter: Action of sulfinpyrazon.
    de Jonge H; Loeliger EA
    Thromb Diath Haemorrh; 1975 Jun; 33(3):674. PubMed ID: 1154325
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacology of sulfinpyrazone (Anturan)].
    Rüegg M
    Wien Med Wochenschr Suppl; 1980; 61():3-8. PubMed ID: 6930768
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
    Haas S; Ketterl R; Blümel G
    Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 6. Mode of action of currently used antiplatelet drugs.
    de Gaetano G; Bertele' V; Cerletti C
    Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelets, cardiac valves and sulphinpyrazone.
    Loeliger EA
    Thromb Haemost; 1982 Apr; 47(2):189. PubMed ID: 7101242
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of sulfinpyrazone on platelet economy and thrombus formation in rabbits.
    Mustard JF; Rowsell HC; Smythe HA; Senyi A; Murphy EA
    Blood; 1967 Jun; 29(6):859-66. PubMed ID: 6029001
    [No Abstract]   [Full Text] [Related]  

  • 9. On the inhibiting effect of sulfinpyrazone on platelets.
    Cortellaro M; Polli EE
    Thromb Res; 1979; 15(5-6):895-6. PubMed ID: 494186
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of warfarin action by sulphinpyrazone.
    Bailey RR; Reddy J
    Lancet; 1980 Feb; 1(8162):254. PubMed ID: 6101699
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic therapy.
    Kazmier FJ
    Cardiovasc Clin; 1983; 13(2):321-33. PubMed ID: 6839327
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulfinpyrazone: relationship between dose, kinetics, plasma concentrations and biological effects.
    Buchanan MR
    Thromb Res Suppl; 1983; 4():89-92. PubMed ID: 6356467
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug interactions and antiplatelet agents.
    Ahmad S
    Am J Cardiol; 1980 Aug; 46(2):341. PubMed ID: 7405849
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombosis prevention by coagulation and platelet aggregtion inhibitors, in hyperlipemic rats.
    Renaud S; Lecompte F
    Thromb Diath Haemorrh; 1970 Dec; 24(3):577-86. PubMed ID: 5503948
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of platelet-affecting drugs.
    Packham MA; Mustard JF
    Circulation; 1980 Dec; 62(6 Pt 2):V26-41. PubMed ID: 6254690
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
    Hatmi M; del Maschio A; Lefort J; de gaetano G; Vargaftig BB; Cerletti C
    J Pharmacol Exp Ther; 1987 May; 241(2):623-7. PubMed ID: 3106620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Comparative effects of platelet suppressant drugs on platelet survival time.
    Genton E; Ellis J; Steele P
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198422
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of pyrazole derivatives on blood platelets.
    Fantl P
    Aust J Exp Biol Med Sci; 1967 Aug; 45(4):355-62. PubMed ID: 6053584
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of thrombosis with antiplatelet drugs.
    Kahn SB
    Am Fam Physician; 1980 May; 21(5):166-8. PubMed ID: 7377074
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
    Buchanan M; Hirsh J
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.